Alprostadil (Caverject/MUSE) Cost in Idaho 2026

What Is Alprostadil and Why Does It Cost So Much in Idaho?

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, producing an erection within 5 to 20 minutes. Two branded delivery systems dominate the U.S. market: Caverject (intracavernosal injection, Pfizer) and MUSE (medicated urethral system for erection, suppository). Both carry list prices that have risen well above inflation since the 1990s.

At Idaho retail pharmacies in 2026, the average cash price for a one-month supply sits near $600 [1]. That figure reflects Pfizer's wholesale acquisition cost for Caverject plus standard pharmacy dispensing margins. Generic injectable alprostadil exists but commands prices within 10 to 15% of the brand, because manufacturing sterile injectable prostaglandins is technically demanding and only a small number of FDA-registered facilities do it [2].

Linet et al. published the landmark randomized controlled trial in the New England Journal of Medicine in 1996 (N=296 men with chronic erectile dysfunction). Alprostadil injection produced intercourse-sufficient erections in 70 to 80% of participants versus fewer than 20% on placebo, a difference that was statistically significant at P<0.001 [3]. That trial underpinned FDA approval and established alprostadil as a first-line agent when oral phosphodiesterase-5 (PDE5) inhibitors fail or are contraindicated.

Idaho does not operate a state-specific pharmaceutical pricing board. Retail prices therefore track national average wholesale price (AWP) schedules. Boise, Meridian, and Twin Falls pharmacies all quote prices in the $550, $650 range for a standard Caverject 10 mcg kit [4].

Idaho Medicaid and Alprostadil: What the Coverage Rules Actually Say

Idaho Medicaid does not cover alprostadil for erectile dysfunction. This is a firm exclusion, not a documentation gap that a prior authorization can overcome.

The Idaho Medicaid preferred drug list (PDL) categorizes erectile dysfunction treatments, including PDE5 inhibitors, as non-covered lifestyle drugs for the general Medicaid population [5]. Alprostadil falls under the same exclusion. Federal Medicaid statute (42 U.S.C. § 1396r-8) permits states to exclude drugs for "cosmetic purposes or erectile dysfunction," and Idaho exercises that option [6].

A narrow exception exists for men whose erectile dysfunction is documented as a direct consequence of a covered medical procedure, such as radical prostatectomy for prostate cancer. Even in that scenario, Idaho Medicaid requires a formal medical necessity review and the outcome is not guaranteed. The Idaho Division of Medicaid has not published a standing policy granting coverage for post-surgical erectile dysfunction, so each case is adjudicated individually [7].

Medicare Part D also generally excludes drugs used "for the treatment of sexual or erectile dysfunction" under 42 C.F.R. § 423.120(b)(5), unless the condition results from a non-sexual dysfunction comorbidity [8]. Idaho beneficiaries enrolled in Medicare Advantage plans should review their plan's Evidence of Coverage document directly, because a small number of plans have added limited erectile dysfunction drug benefits as supplemental coverage since 2023.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism notes that testosterone deficiency can cause erectile dysfunction and that alprostadil may be necessary when testosterone alone fails to restore function [9]. Documenting hypogonadism alongside erectile dysfunction does not by itself reveal Idaho Medicaid coverage, but it may strengthen a coverage appeal to a private insurer.

Compounded Alprostadil in Idaho: Legality and Price Advantage

Compounded alprostadil from a 503A-licensed pharmacy is legal in Idaho, and it is the single largest cost-reduction lever available to most patients.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies may prepare patient-specific alprostadil formulations when a licensed prescriber issues a valid prescription [10]. Idaho follows federal 503A rules without additional state restrictions on compounding sterile injectables, provided the pharmacy holds the required sterile compounding accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or an equivalent body [11].

Compounded intracavernosal alprostadil typically costs $0, $50 per month when dispensed through a telehealth-affiliated compounding pharmacy, compared with the $600 retail price for Caverject. The price difference arises because compounders purchase bulk pharmaceutical-grade alprostadil API at wholesale, bypassing Pfizer's brand markup. A 30-day supply of 10 mcg/mL compounded alprostadil syringes commonly retails for $30, $60 before any telehealth platform subsidy [12].

Compounded alprostadil is not FDA-approved, which means it has not undergone the same sterility, potency, and stability testing as Caverject. The FDA's guidance on compounded drug products states that compounded drugs "lack an FDA finding of safety and effectiveness" [13]. Clinically, this means patients should use only PCAB-accredited pharmacies and store compounded alprostadil according to pharmacy instructions, typically at 2, 8°C, discarding unused product after the beyond-use date printed on the label.

Tri-mix (alprostadil combined with phentolamine and papaverine) is also available through 503A compounders in Idaho and may produce stronger erections at lower individual-drug doses. The American Urological Association 2018 guideline on erectile dysfunction recognizes tri-mix as an accepted intracavernosal option when alprostadil monotherapy is insufficient [14].

Private Insurance Coverage for Alprostadil in Idaho

Private insurance coverage for alprostadil varies significantly by plan, and Idaho residents must check their specific formulary.

Most commercial plans sold on the Idaho Your Health Idaho exchange (ACA marketplace) treat erectile dysfunction drugs as a non-essential health benefit category. They may cover alprostadil if the prescriber documents a non-sexual comorbidity, such as peripheral vascular disease or Peyronie's disease, driving the erectile dysfunction [15]. Without that documentation, pharmacy benefit managers typically reject alprostadil claims at the point of sale.

Employer-sponsored plans governed by ERISA are not required to cover erectile dysfunction drugs. A 2021 analysis in JAMA found that fewer than 19% of large-employer health plans included any erectile dysfunction drug on their formulary, and most that did required a Step Edit demonstrating failure of an oral PDE5 inhibitor first [16]. Idaho employers with self-insured plans have full discretion over formulary design.

Blue Cross of Idaho, the state's largest commercial insurer, lists Caverject on its specialty tier for members whose plans include erectile dysfunction benefits. Out-of-pocket costs on covered plans after meeting deductible typically run $150, $250 per month, depending on the specific benefit design [17].

If your plan covers alprostadil, you will likely need:

1. A diagnosis code consistent with organic erectile dysfunction (ICD-10 N52.01, N52.9).
2. Documentation of failure or contraindication to at least one oral PDE5 inhibitor (sildenafil or tadalafil).
3. A prior authorization form completed by your prescriber.

Peyronie's disease (ICD-10 N48.6) is a separate FDA-approved indication for intralesional alprostadil and may have a different coverage pathway on some plans [18].

How Much Does Alprostadil Cost Without Insurance in Idaho?

Cash-paying patients in Idaho face a $550, $650 retail price for a standard Caverject kit. There are several strategies to reduce that cost materially.

GoodRx and pharmacy discount cards. GoodRx codes for Caverject 10 mcg (6 vials) show prices of $480, $530 at Boise-area pharmacies as of early 2026. These codes cannot be combined with insurance. Mark Cuban's Cost Plus Drugs does not currently stock Caverject, but does list generic alprostadil injection at $140 for 10 vials of 20 mcg/mL, a significant reduction [19].

Pfizer savings card. Pfizer's RxPathways program offers a savings card for commercially insured patients that may reduce out-of-pocket Caverject costs to $0, $25 per fill. Patients enrolled in any federal or state government program (Medicaid, Medicare, TRICARE) are not eligible [20]. Idaho residents can enroll at pfizerrxpathways.com or through their prescribing physician's office.

Patient assistance programs. Pfizer's Pfizer RxPathways also maintains an uninsured/underinsured program for patients below 400% of the federal poverty level ($58,320 for a single person in 2026). Eligible patients may receive Caverject at no cost [21]. Documentation required includes proof of Idaho residency, income verification, and a valid prescription.

Compounded alprostadil via telehealth. This is the most cost-effective path for most Idaho patients without insurance. Several telehealth platforms licensed in Idaho prescribe and dispense compounded alprostadil for $30, $80 per month, all-in, including the prescriber consultation fee [22].

Telehealth Prescribing of Alprostadil in Idaho

Telehealth prescribing of alprostadil is fully legal in Idaho, and it has become the primary access route for men outside the Treasure Valley.

Idaho enacted its telehealth practice act under Idaho Code § 54-5701, which establishes that a valid patient-physician relationship can be formed via synchronous audio-video encounter [23]. A prescriber licensed in Idaho may issue an alprostadil prescription following a telehealth visit that includes a thorough sexual health history, cardiovascular risk assessment, and review of any prior erectile dysfunction treatments.

The Idaho Medical Practice Act does not require an in-person physical examination before prescribing alprostadil, but the prescriber must document a clinical basis for the prescription that meets the standard of care [24]. The American Urological Association's erectile dysfunction guideline, updated in 2018, recommends that intracavernosal therapy be accompanied by an in-office injection training session to teach proper technique and observe for priapism [14]. Telehealth platforms handling alprostadil should, at minimum, provide video-based injection technique instruction and a written protocol for managing prolonged erections lasting more than four hours.

Men in rural Idaho counties (Camas, Clark, Lemhi, and others with limited urology access) benefit most from telehealth prescribing. The nearest urologist to Salmon, Idaho, for example, is approximately 160 miles away. A telehealth-initiated alprostadil prescription with compounded pharmacy delivery can compress that access gap to a few business days.

Dosing, Administration, and Safety Context

Alprostadil doses for intracavernosal injection range from 2.5 mcg to 40 mcg per injection. The starting dose is typically 2.5 mcg, titrated upward in a clinical setting until a satisfactory erection lasting 60 minutes or less is achieved [25]. MUSE urethral suppositories are available in 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg strengths, with the 500 mcg and 1 to 000 mcg doses showing the greatest efficacy in clinical trials [3].

The most serious adverse event is priapism, defined as an erection lasting more than four hours. In the Linet et al. trial, priapism requiring intervention occurred in 1% of participants [3]. Patients must receive written instructions to go to an emergency department immediately if an erection does not resolve within four hours. Corporal irrigation with dilute phenylephrine is the standard treatment per American Urological Association protocol [14].

Penile pain at the injection site is the most common adverse event, reported by 10 to 37% of users in published series [26]. MUSE suppositories cause urethral burning in approximately 30% of users and may transfer alprostadil to a female partner, producing vaginal burning [27]. The FDA prescribing information for Caverject states that contraindications include conditions predisposing to priapism, such as sickle cell anemia, multiple myeloma, and leukemia [28].

The prescribing information also notes that alprostadil should not be used more than once in any 24-hour period and no more than three times per week, because more frequent use increases fibrosis risk at the injection site [28].

Comparing Alprostadil to PDE5 Inhibitors in Idaho: A Cost Perspective

Most Idaho prescribers follow a step-therapy approach: oral PDE5 inhibitors first, alprostadil second.

Generic sildenafil 100 mg tablets cost $1.00, $2.00 per tablet at Idaho pharmacies through discount programs, making it the far cheaper first-line option [29]. Tadalafil 5 mg daily generic costs roughly $15, $30 per month [30]. When PDE5 inhibitors fail, which occurs in 30 to 40% of men with severe organic erectile dysfunction per a 2019 meta-analysis in the Journal of Sexual Medicine (N=4,840), alprostadil becomes medically necessary [31].

PDE5 inhibitors require intact nitric oxide pathways and are ineffective after complete bilateral nerve-sparing failure in radical prostatectomy. In that population, early use of alprostadil has been shown to support penile rehabilitation. A randomized trial published in European Urology (N=112) found that men using alprostadil three times per week after nerve-sparing radical prostatectomy had significantly better spontaneous erection recovery at 12 months compared with controls [32]. This evidence base makes alprostadil more than a backup drug for a specific subset of Idaho patients.

HealthRX Clinician Perspective on Idaho Access

The HealthRX medical team reviews alprostadil cases from Idaho patients using a three-tier access framework:

Tier 1 (preferred): Compounded alprostadil via 503A telehealth. Suitable for patients without insurance coverage, patients who have failed oral PDE5 inhibitors, and patients who prefer lower cost. Requires PCAB-accredited pharmacy. Monthly cost target: under $60.

Tier 2: Brand Caverject with Pfizer savings card or patient assistance. Suitable for commercially insured patients or uninsured patients who meet income criteria. The FDA-approved product may be preferable for men with complex comorbidities where batch-to-batch consistency matters most.

Tier 3: MUSE urethral suppository. Suitable for patients who cannot self-inject or who have a needle phobia. Lower efficacy than injection (30 to 60% response versus 70 to 80% for injection) but non-invasive [33]. Cost is similar to Caverject at retail.

Every tier requires a valid Idaho-licensed prescriber. The prescriber must document the indication, prior therapy failure, cardiovascular clearance, and injection technique training plan.

"The goal of intracavernosal therapy is a 30-minute erection sufficient for intercourse, not a pharmacological maximum," according to the Endocrine Society's position on male sexual dysfunction. "Dose titration in a supervised clinical setting reduces the risk of priapism and fibrosis and should not be skipped." [9]

Step-by-Step: Getting Alprostadil in Idaho in 2026

1. Book a telehealth visit with an Idaho-licensed prescriber through a platform such as HealthRX. The visit takes 20 to 30 minutes and covers cardiovascular clearance, medication review, and erectile dysfunction history.
2. Receive your prescription. The prescriber sends it directly to a PCAB-accredited compounding pharmacy (for compounded alprostadil) or to your local Idaho pharmacy (for Caverject or MUSE).
3. Apply cost-reduction programs. If insured, check formulary and request prior authorization. If uninsured, apply for Pfizer RxPathways or request compounded alprostadil pricing.
4. Attend injection training. Watch your platform's video module, and contact the prescribing team with any technique questions before your first self-injection.
5. Start at the lowest effective dose. Begin at 2.5 mcg for injection or 250 mcg for MUSE. Return for a virtual dose-titration check at two weeks.
6. Know the priapism protocol. If an erection lasts more than four hours, go to the nearest Idaho emergency department immediately. Saint Alphonsus Regional Medical Center (Boise), St. Luke's Health System, and Eastern Idaho Regional Medical Center all have 24-hour emergency urology on-call [34].